Ngomhlaka-5 Januwari 2021, iShangke Biopharmaceutical (Shanghai) Co., Ltd. yanikezwa iphrojekthi ye-"(S)-1-tert-butoxycarbonyl-3-hydroxypiperidine" yeShanghai High-tech Achievement Transformation Project.
Njengebhizinisi likazwelonke lobuchwepheshe obuphezulu, i-Suntech Biotech ihlala isebenzisa ubuchwepheshe be-bio ukuhola intuthuko yemboni yamakhemikhali nemithi, futhi iletha uhlaza kanye nempilo kubantu njengomgomo wayo. Ukwandisa ibhizinisi ngezindlela eziningi, ukubambisana ngenkuthalo nezikole namabhizinisi adumile ekhaya nakwamanye amazwe, ukuthuthukisa njalo amandla ayo okuthuthukiswa, ukwenza ngcono ukwakheka kwangaphakathi kwebhizinisi, futhi libe ngcono futhi liqine.
Igama lephrojekthi: (S)-1-tert-Butoxycarbonyl-3-hydroxypiperidine
Inombolo Yento: 202010694
Izinga lento: B
Kungakhathaliseki ukuthi kukhona yini impumelelo emkhakheni wezobuchwepheshe obuphezulu onamalungelo obunikazi azimele: Yebo
Ukusetshenziswa: (S)-1-tert-butoxycarbonyl-3-hydroxypiperidine (CAS: 143900-44-1) iwumuthi obalulekile we-chiral wokwenziwa kwama-API e-ibrutinib. I-Ibrutinib iwumuthi omusha wokulwa nomdlavuza ohlose umdlavuza we-B-cell owavunywa ngaphansi kokuvunyelwa okusheshayo yi-US Food and Drug Administration (FDA) ngoNovemba 13, 2013 wokwelapha i-lymphoma.
Incazelo yokuguqulwa kwempumelelo yobuchwepheshe obuphezulu
Ukuguqulwa kwezimpumelelo zobuchwepheshe obuphezulu kubhekisela enkambisweni lapho amabhizinisi enza khona ukukhiqizwa nokusebenza kobuchwepheshe obuphezulu. Umbuso usekela amabhizinisi ukuthi aqalise ukuguqulwa kwezimpumelelo zesayensi nezobuchwepheshe ngocwaningo oluzimele kanye nentuthuko, ukunikeza amalayisense, ukuthatha amasheya ngentengo, kanye nokubambisana nezimboni, amanyuvesi kanye nezikhungo zocwaningo. Kumaphrojekthi okuguqulwa kwempumelelo yobuchwepheshe obuphezulu abuyekezwa futhi abikwe yibhizinisi, ngokuya ngokuqedwa kwezinkomba zalo eziphelele zomnotho kanye nezimfanelo zamalungelo empahla yobuhlakani yephrojekthi, izinga lokusungula izinto ezintsha, njll., ukutshalwa kwezimali kwalo kwe-R&D kuhlobene namalungelo empahla yobuhlakani ahlobene nephrojekthi, izitifiketi ze-patent zokusungula izinto ezintsha, noma lawo angena esigabeni sokuhlolwa esibalulekile. Isitifiketi sodumo esinikezwa ibhizinisi ngemuva kokubuyekezwa okuqinile kanye nophenyo olunzulu lwemakethe, njengezinto zobufakazi zesicelo se-patent sokusungula izinto ezintsha, isitifiketi se-patent yemodeli yokusetshenziswa, isitifiketi sokubhaliswa kwe-copyright yesofthiwe, isitifiketi sokubhaliswa komklamo wesifunda esihlanganisiwe, njll.
Iphrofayela Yenkampani
I-Shangke Biomedical (Shanghai) Co., Ltd. yasungulwa ngo-2008 futhi itholakala e-International Medical Park, indawo eseningizimu ye-Zhangjiang Hi-Tech Park, ePudong, eShanghai. Iyinkampani engaphansi kwe-Zhejiang Shangke Biomedical Co., Ltd. I-Shangke Biomedical Co., Ltd. I-Shangke Bio izinikele ocwaningweni nasekuthuthukisweni kwensimu yezokwelapha eluhlaza esezingeni eliphezulu, ihola intuthuko yemboni yezokwelapha yamakhemikhali nge-biotechnology eluhlaza, futhi inikeza imikhiqizo emisha kanye nezinsizakalo ezisezingeni eliphezulu embonini yezokwelapha. Iyibhizinisi lobuchwepheshe obuphezulu eShanghai futhi iyibhizinisi lobuchwepheshe obuphezulu laseShanghai "elikhethekile, elicwengisisiwe, elikhethekile nelisha".
Ibhizinisi eliyinhloko le-Suntech lifaka: ukuthuthukiswa nokusetshenziswa kwama-enzyme ezinto eziphilayo, ukuthuthukiswa nokukhiqizwa kwama-medicine intermediates, ama-API namakhemikhali asebenzayo. Imikhiqizo eyinhloko yenkampani yimikhiqizo ye-coenzyme, okuhlanganisa i-NMN, i-NAD, i-NADP, i-NADH, i-NADPH, ama-enzyme ezinto eziphilayo, izinto zokusetshenziswa kwemithi kanye nama-medicine intermediates. Amakhasimende nabalingani benkampani basemhlabeni wonke, futhi bakhe ubudlelwano obuseduze nezinkampani eziningi zemithi eNyakatho Melika, eYurophu, eNdiya naseShayina.
Isikhathi sokuthunyelwe: Jan-15-2021